cytosine has been researched along with Arteriosclerosis, Coronary in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, J | 3 |
| Joehanes, R | 3 |
| Liu, C | 3 |
| Keshawarz, A | 3 |
| Hwang, SJ | 3 |
| Bui, H | 3 |
| Tejada, B | 3 |
| Sooda, M | 3 |
| Munson, PJ | 3 |
| Demirkale, CY | 3 |
| Courchesne, P | 3 |
| Heard-Costa, NL | 3 |
| Pitsillides, AN | 3 |
| Feolo, M | 3 |
| Sharopova, N | 3 |
| Vasan, RS | 3 |
| Huan, T | 3 |
| Levy, D | 3 |
| Cai, GJ | 1 |
| He, GP | 1 |
| Huang, ZY | 1 |
| Qi, CP | 1 |
| Opstad, TB | 1 |
| Arnesen, H | 1 |
| Pettersen, AÅ | 1 |
| Seljeflot, I | 1 |
| Rossi, GP | 1 |
| Maiolino, G | 1 |
| Wong, CW | 1 |
| Christen, T | 1 |
| Pfenniger, A | 1 |
| James, RW | 1 |
| Kwak, BR | 1 |
| Martinelli, N | 1 |
| Trabetti, E | 2 |
| Bassi, A | 1 |
| Girelli, D | 1 |
| Friso, S | 1 |
| Pizzolo, F | 1 |
| Sandri, M | 1 |
| Malerba, G | 1 |
| Pignatti, PF | 2 |
| Corrocher, R | 1 |
| Olivieri, O | 1 |
| Bernardo, E | 1 |
| Angiolillo, DJ | 1 |
| Ramírez, C | 1 |
| Cavallari, U | 1 |
| Sabaté, M | 1 |
| Hernández, R | 1 |
| Moreno, R | 1 |
| Escaned, J | 1 |
| Alfonso, F | 1 |
| Bañuelos, C | 1 |
| Costa, MA | 1 |
| Bass, TA | 1 |
| Macaya, C | 1 |
| Fernandez-Ortiz, A | 1 |
| Hoefle, G | 1 |
| Muendlein, A | 1 |
| Saely, CH | 1 |
| Risch, L | 1 |
| Rein, P | 1 |
| Koch, L | 1 |
| Schmid, F | 1 |
| Aczel, S | 1 |
| Marte, T | 1 |
| Langer, P | 1 |
| Drexel, H | 1 |
| Boettiger, C | 1 |
| Koch, W | 1 |
| Mehilli, J | 1 |
| Schoemig, A | 1 |
| Kastrati, A | 1 |
| Wittwer, J | 1 |
| Bayer, M | 1 |
| Mosandl, A | 1 |
| Muntwyler, J | 1 |
| Hersberger, M | 1 |
| Nishijima, T | 1 |
| Nakayama, M | 1 |
| Yoshimura, M | 1 |
| Abe, K | 1 |
| Yamamuro, M | 1 |
| Suzuki, S | 1 |
| Shono, M | 1 |
| Sugiyama, S | 1 |
| Saito, Y | 1 |
| Miyamoto, Y | 1 |
| Nakao, K | 1 |
| Yasue, H | 1 |
| Ogawa, H | 1 |
1 trial available for cytosine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Cytosine; Female; Genetic Association Studi | 2014 |
10 other studies available for cytosine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Elucidating the genetic architecture of DNA methylation to identify promising molecular mechanisms of disease.
Topics: Coronary Artery Disease; COVID-19; CpG Islands; Cytosine; Diabetes Mellitus, Type 2; DNA Methylation | 2022 |
Lack of association between a common polymorphism of the endothelial lipase gene and early-onset coronary artery disease in a Chinese Han population.
Topics: Asian People; Case-Control Studies; Coronary Artery Disease; Cytosine; Female; Gene Frequency; Genet | 2014 |
T-786C and G894T variants of the endothelial nitric oxide synthase gene and training-induced correction of endothelial dysfunction in coronary artery disease patient.
Topics: Coronary Artery Disease; Cytosine; Endothelium, Vascular; Exercise Therapy; Exons; Guanine; Humans; | 2004 |
Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction?
Topics: Aged; Alleles; Connexins; Coronary Angiography; Coronary Artery Disease; Cytosine; Female; Gap Junct | 2007 |
The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Topics: Adult; Aged; Apolipoprotein A-V; Apolipoprotein C-III; Apolipoproteins A; Coronary Angiography; Coro | 2007 |
Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease.
Topics: Adult; Aged; Alleles; Analysis of Variance; Biomarkers; C-Reactive Protein; Coronary Artery Disease; | 2006 |
The -11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men.
Topics: Adiponectin; Cardiovascular Diseases; Cohort Studies; Coronary Angiography; Coronary Artery Disease; | 2007 |
Glycoprotein VI polymorphisms and outcome after percutaneous coronary interventions.
Topics: Angioplasty, Balloon, Coronary; CD36 Antigens; Cohort Studies; Coronary Artery Disease; Coronary Res | 2007 |
The c.-292C>T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective.
Topics: Arachidonate 15-Lipoxygenase; Atherosclerosis; Case-Control Studies; Chromatography, High Pressure L | 2007 |
The endothelial nitric oxide synthase gene -786T/C polymorphism is a predictive factor for reattacks of coronary spasm.
Topics: Adult; Aged; Calcium Channel Blockers; Cause of Death; Coronary Artery Disease; Coronary Vasospasm; | 2007 |